Connect Biopharma is trading at $2.49 (+5.73%) in after-hours trading, buoyed by a broad biotech sector bid and continued momentum.
- No fresh company-specific announcements were identified for July 14, 2026, suggesting the move is driven by sector sentiment rather than a new catalyst.
- The stock has been trending higher recently amid analyst optimism and high expectations for upcoming clinical data.